OssDsign announces the establishment of a U.S. Strategic Surgeon Advisory Board

Uppsala, June 7, 2022. OssDsign AB (publ.) today announces that the company has established a Strategic Surgeon Advisory Board (SSAB) in the U.S. The primary objective of the SSAB is to assist the company with guidance and advice on strategic matters.The SSAB will consist of seven leading U.S. neurosurgical and orthopaedic spinal surgeons who will advise the company on matters related to the future direction and priorities for the company such as new product development, regulatory pathways, clinical programs and similar areas that carry strategic importance. OssDsign’s SSAB will